Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression

被引:25
作者
Wincewicz, D. [1 ,3 ]
Juchniewicz, A. [2 ]
Waszkiewicz, N. [3 ]
Braszko, Jj. [1 ]
机构
[1] Med Univ Bialystok, Dept Clin Pharmacol, Waszyngtona 15a, PL-15274 Bialystok, Poland
[2] Med Univ Bialystok, Dept Clin Mol Biol, Bialystok, Poland
[3] Med Univ Bialystok, Dept Psychiat, Bialystok, Poland
关键词
Angiotensin II; ARB; Telmisartan; Stress; PPAR-gamma; GW9662; BDNF; PPAR-GAMMA AGONIST; FOCAL CEREBRAL-ISCHEMIA; PREFRONTAL CORTEX; COGNITIVE DECLINE; HYPERTENSIVE-RATS; ANTAGONIST; IMPROVES; ACTIVATION; SYSTEM; HIPPOCAMPUS;
D O I
10.1016/j.pbb.2016.06.010
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Physical and psychological aspects of chronic stress continue to be a persistent clinical problem for which new pharmacological treatment strategies are aggressively sought. By the results of our previous work it has been demonstrated that telmisartan (TLM), an angiotensin type 1 receptor (AT(1)) blocker (ARB) and partial agonist of peroxisome proliferator-activated receptor gamma (PPAR gamma), alleviates stress-induced cognitive decline. Understanding of mechanistic background of this phenomenon is hampered by both dual binding sites of TLM and limited data on the consequences of central AT(1) blockade and PPAR gamma activation. Therefore, a critical need exists for progress in the characterization of this target for pro-cognitive drug discovery. An unusual ability of novel ARBs to exert various PPAR gamma binding activities is commonly being viewed as predominant over angiotensin blockade in terms of neuroprotection. Here we aimed to verify this hypothesis using an animal model of chronic psychological stress (Wistar rats restrained 2.5 h daily for 21 days) with simultaneous oral administration of TLM (1 mg/kg), GW9662 - PPAR gamma receptor antagonist (0.5 mg/kg), or both in combination, followed by a battery of behavioral tests (open field, elevated plus maze, inhibitory avoidance - IA, object recognition - OR), quantitative determination of serum corticosterone (CORT) and evaluation of brain-derived neurotrophic factor (BDNF) gene expression in the medial prefrontal cortex (mPFC) and hippocampus (HIP). Stressed animals displayed decreased recall of the IA behavior (p < 0.001), decreased OR (p < 0.001), substantial CORT increase (p < 0.001) and significantly downregulated expression of BDNF in the mPFC (p < 0.001), which were attenuated in rats receiving TLM and TLM + GW9662. These data indicate that procognitive effect of ARBs in stressed subjects do not result from PPAR-gamma activation, but AT(1), blockade and subsequent hypothalamus-pituitary-adrenal axis deactivation associated with changes in primarily cortical gene expression. This study confirms the dual activities of TLM that controls hypertension and cognition through AT(1) blockade. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:108 / 118
页数:11
相关论文
共 73 条
  • [1] RETENTION OF A PASSIVE AVOIDANCE RESPONSE AS A FUNCTION OF INTENSITY AND DURATION OF ELECTRIC SHOCK
    ADER, R
    MOLEMAN, P
    WEIJNEN, JAW
    [J]. PSYCHONOMIC SCIENCE, 1972, 26 (03): : 125 - &
  • [2] Environmental stress and psychiatric illness
    Agid, O
    Kohn, Y
    Lerer, B
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (03) : 135 - 141
  • [3] Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests
    Ahmed, Amany Ali Eissa
    Al-Rasheed, Nawal Mohammed
    Al-Rasheed, Nouf Mohammed
    [J]. BEHAVIOURAL PHARMACOLOGY, 2009, 20 (07): : 635 - 642
  • [4] AT1 Receptor Antagonism Is Proangiogenic in the Brain: BDNF a Novel Mediator
    Alhusban, Ahmed
    Kozak, Anna
    Ergul, Adviye
    Fagan, Susan C.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (02) : 348 - 359
  • [5] Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
    Anderson, Craig
    Teo, Koon
    Gao, Peggy
    Arima, Hisatomi
    Dans, Antonio
    Unger, Thomas
    Commerford, Patrick
    Dyal, Leanne
    Schumacher, Helmut
    Pogue, Janice
    Paolasso, Ernesto
    Holwerda, Nicolaas
    Chazova, Irina
    Binbrek, Azan
    Young, James
    Yusuf, Salim
    [J]. LANCET NEUROLOGY, 2011, 10 (01) : 43 - 53
  • [6] More indirect evidence of potential neuroprotective benefits of angiotensin receptor blockers
    Anderson, Craig
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 (03) : 429 - 429
  • [7] Peripheral administration of an angiotensin II AT1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress
    Armando, I
    Carranza, A
    Nishimura, Y
    Hoe, KL
    Barontini, M
    Terrón, JA
    Falcón-Neri, A
    Ito, T
    Juorio, AV
    Saavedra, JM
    [J]. ENDOCRINOLOGY, 2001, 142 (09) : 3880 - 3889
  • [8] Angiotensin II AT1 receptor blockade prolongs the lifespan of spontaneously hypertensive rats and reduces stress-induced release of catecholamines, glucocorticoids, and vasopressin
    Baiardi, G
    Bregonzio, C
    Jezova, M
    Armando, I
    Saavedra, JM
    [J]. STRESS: CURRENT NEUROENDOCRINE AND GENETIC APPROACHES, 2004, 1018 : 131 - 136
  • [9] Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
    Benson, SC
    Pershadsingh, HA
    Ho, CI
    Chittiboyina, A
    Desai, P
    Pravenec, M
    Qi, NN
    Wang, JM
    Avery, MA
    Kurtz, TW
    [J]. HYPERTENSION, 2004, 43 (05) : 993 - 1002
  • [10] Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity
    Berger, J
    Tanen, M
    Elbrecht, A
    Hermanowski-Vosatka, A
    Moller, DE
    Wright, SD
    Thieringer, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) : 12629 - 12635